semaglutide not ozempic Type 2 diabetes: New pill now available in the U.S Ozempic knockoffs flood US market

Support materials, dosing protocols, and access to provider guidance ensure that non-diabetic patients new to GIP-GLP-1 receptor agonists feel confident managing their treatment independently

Oxytocin's potential influence in the brain may extend to neurogenesis and synaptic plasticity, which may impact the intricate dance of neural circuit formation and function

Sohn JH, Kim CH, Lee SH, Kim JH, Lee JJ

Elevated Heart Rate: L-carnitine may increase heart rate and blood pressure in some individuals, posing risks for those with existing cardiovascular conditions

Mounjaro is a new once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist, and is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes